Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Transl Res. 2020 May 1;221:65–82. doi: 10.1016/j.trsl.2020.03.013

Table 3.

Pharmaceutical agents with potential to target aging processes

Agent Mechanism Targets
Rapamycin Inhibits mammalian target of rapamycin (mTOR).  •  Loss of proteostasis
 •  Dysregulated nutrient sensing
 •  Mitochondrial dysfunction
 •  Stem cell exhaustion
Metformin Modulates glucose metabolism, decreases insulin and insulin like growth factor signaling, inhibits mTOR and mitochondrial complex 1. activates AMP-Kinase and reduces DNA damage  •  Genomic instability
 •  Loss of proteostasis
 •  Dysregulated nutrient sensing
 •  Mitochondrial dysfunction
Nicotinamide Riboside Precursor for NAD+ (NAD regulates the energy balance, stress response, and cellular homeostasis through sirtuins, PARPs and various redox enzymes)  •  Genomic instability
 •  Dysregulated nutrient sensing
 •  Mitochondrial dysfunction
Dasatinib and Quercetin Senolytic  •  Cellular senescence
TTP448 Receptor for advanced glycation end-products inhibitor  •  Intracellular communication
 •  Genomic instability